Toxicological Characteristics Of N-Deacetyllappaconitine Under Chronic Administration In White Rats

Abstract

Keywords

References

1. Gorenek B., Blomstrom Lundqvist C., Brugada Terradellas J., et al. Cardiac arrhythmias in acute coronary syndromes: position paper from the joint EHRA, ACCA, and EAPCI task force. Europace. 2014; 16:1655-73.
2. Rahimi K., Watzlawek S., Thiele H., et al. Incidence, time course, and predictors of early malignant ventricular arrhythmias after non-ST-segment elevation myocardial infarction in patients with early invasive treatment. Eur Heart J. 2006; 27:1706-11.
3. Gogolashvili N.G., Litvinenko M.V., Pochikaeva T.N., et al. Ventricular arrhythmia prevalence and treatment with omega-3 polyunsaturated fatty acids in patients who suffered myocardial infarction within the last year. Kardiovaskulyarnaya Terapiya i Profilaktika. 2011;10(5):57-62.
4. Gogolashvili N.G., Litvinenko M.V., Pochikaeva T.N. et al. Possibilities of apreparation omega-3 polyunsaturated fatty acids in the treatment of patients with ventricular arrhythmias and myocardial infarction. Kardiologiia. 2011;51(8):28-31.
5. Parmon E.V., Treshkur T.V., Shlyakhto E.V. Idiopathic ventricular arrhythmias (problem analysis). Vestnik Aritmologii. 2003; 31:60-71.
6. Hwang J.K., Park S.J., On Y.K., et al. Clinical characteristics and features of frequent idiopathic ventricular premature complexes in the Korean population. Korean Circ J. 2015;45(5):391-7.
7. Cheriyath P., He F., Peters I., et al. Relation of atrial and/or ventricular premature complexes on a twominute rhythm strip to the risk of sudden cardiac death (the atherosclerosis risk in communities [ARIC] study). Am J Cardiol. 2011;107(2):151-5.
8. Ephrem G., Levine M., Friedmann P., Schweitzer P. The prognostic significance of frequency and morphology of premature ventricular complexes during ambulatory holter monitoring. Ann Noninvasive Electrocardiol. 2013;18(2):118-25.
9. Agarwal S.K., Simpson R.J. Jr., Rautaharju P., et al. Relation of ventricular premature complexes to heart failure (from the Atherosclerosis Risk In Communities [ARIC] Study). Am J Cardiol. 2012;109(1): 105-9.
10. Piccini J.P., White J.A., Mehta R.H., et al. Sustained ventricular tachycardia and ventricular fibrillation complicating non-ST-segment-elevation acute coronary syndromes. Circulation. 2012;126(1): 41-9.
11. Mamchur S.E., Ardashev A.V. Sudden cardiac death and Wolff-Parkinson-White syndrome. Vestnik Aritmologii. 2014; 76:30-6.
12. Dukes J.W., Dewland T.A., Vittinghoff E., et al. Ventricular ectopy as a predictor of heart failure and death. J Am Coll Cardiol. 2015;66(2):101-9.
13. Akhiyarov A.A., Lobov A.N., Ivanov S.P., Spirikhin L.V., Gabbasov T.M., Tsyrlina E.M., Yunusov M.S., Valiev N.V., Sadikov A.Z., Sagdullaev S.S. Antiarrhythmic agents based on diterpenoid alkaloid lappaconitine. protonation of N-deacethyllappaconitine in methanol solutions. Russian Chemical Bulletin. 2020. Т. 69. №‎3, 567-571.
14. Sanoev, Z.I., Khamroev, T.T., Djaxangirov, F.N., Sadikov, A.Z., Sagdullaev, S.S. Antiarrhythmic activity of N-deacety lappaconitine when administered orally. Annals of the Romanian Society for Cell Biology,2021,25(2), 2339–2346
15. Good Laboratory Practice (GLP). State Standard of the Republic of Uzbekistan. O’z DSt 2762:2018. Ministry of Health of the Republic of Uzbekistan
16. Sanoev, Z.I., Mirzaev, Y.R. Research of a new atypical neuroleptic 1-(3,4,-methylenedioxyphenyl)-6,7-methylenedioxy-1,2,3,4-tetrahydroisoquinoline on the central nervous system. Annals of the Romanian Society for Cell Biology,2021,25(2), 2363–2369